CPIX - Income Statement - Cumberland Pharmaceuticals Inc.

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015	Dec-2014	Dec-2013	Dec-2012	Dec-2011	Dec-2010	Dec-2009	Dec-2008	Dec-2007	Dec-2006	Dec-2005
REVENUE
Revenue	37.9	39.6	42.0	36.0	37.4	34.4	40.7	41.2	33.0	33.5	36.9	32.0	48.9	51.1	45.9	43.5	35.1	28.1	17.8	10.7
GROSS PROFIT
Cost Of Revenue	6.6	6.1	9.1	8.8	8.7	7.4	7.4	7.4	6.0	5.0	5.1	5.4	5.0	5.4	3.6	4.1	3.0	2.7	2.4	0.5
Gross Profit	31.3	33.5	32.9	27.2	28.8	27.0	33.4	33.8	27.1	28.6	31.8	26.6	43.8	45.8	42.3	39.4	32.0	25.4	15.4	10.2
OPERATING INCOME
Operating Expenses	33.5	43.0	38.6	34.9	35.2	36.3	40.8	37.9	28.5	27.4	28.3	30.4	35.0	35.9	35.8	33.6	24.7	18.7	13.2	9.4
Selling, General and Administrative Expenses	28.1	29.1	26.8	24.8	25.0	25.3	30.7	31.5	23.1	21.6	23.3	23.9	29.4	30.1	30.7	27.8	19.5	14.2	10.3	8.2
Research and Development Expenses	4.8	5.8	6.7	5.7	5.8	6.9	7.3	3.9	3.2	3.8	3.4	5.6	5.1	5.0	4.3	5.0	4.4	3.7	2.2	1.2
Operating Income	(7.1)	(6.2)	(5.7)	(7.7)	(6.4)	(9.3)	(7.4)	(4.1)	(1.4)	(1.1)	3.6	(3.8)	8.8	9.8	6.5	5.8	7.3	6.7	2.2	0.7
PRE-TAX INCOME
Interest Income Expense	0.6	0.7	0.6	98 K	0.3	0.2	0.2	92.9 K	0.1	73.9 K	67.1 K	0.1	72 K	0.4	1.4	0.8	0.2	0.6	0.7	63.2 K
Total Other Income	0.6	74.2 K	0.1	2.1	(0.2)	2.82 K	0.4	0.2	98.3 K	0.1	0.2	0.1	0.2	(0.1)	(1.2)	(0.7)	28 K	(0.3)	(0.5)	20.4 K
Pre-Tax Income	(6.5)	(6.3)	(5.6)	(5.6)	(6.6)	(9.3)	(7.0)	(3.9)	(1.3)	1.2	3.7	(3.7)	9.1	9.7	5.3	5.1	7.3	6.5	1.7	0.8
NET INCOME
Tax Provision	22.7 K	45.8 K	68.8 K	34.9 K	55.9 K	79.3 K	16.6 K	4.2	(0.3)	0.6	1.4	(1.5)	3.2	4.1	2.9	2.0	2.5	2.4	(2.7)	(1.2)
Net Income	(6.5)	(6.3)	(5.7)	(5.6)	(6.6)	(9.2)	(7.0)	(8.0)	(0.9)	0.7	2.4	(2.1)	5.8	5.7	2.5	3.1	4.8	4.0	4.4	2.0
EPS	0.46	0.44	0.39	0.38	0.44	0.6	0.45	0.5	0.06	0.04	0.14	0.11	0.3	0.28	0.12	0.22	0.47	0.4	0.45	0.21

Free